TY - JOUR
T1 - Infant HPA axis as a potential mechanism linking maternal mental health and infant telomere length
AU - Nelson, Benjamin W.
AU - Allen, Nicholas B.
AU - Laurent, Heidemarie
N1 - Funding Information:
This research was supported by grants from The Mind and Life Institute (1440 Research Award 2015-1440-Nelson) awarded to the first author and The Society for Research in Child Development Victoria Levin Award and the University of Oregon College of Arts and Sciences issued to the last author. The funding sources had no role in the study design, data collection and analysis, or submission process. We thank Elissa Epel, Ph.D. for her consultation on our study design and Jue Lin, Ph.D. and Elizabeth Blackburn, Ph.D. for their expertise in assaying the telomere samples.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2018/2
Y1 - 2018/2
N2 - Maternal depression has been suggested to be an independent risk factor for both dysregulated hypothalamic-pituitary-adrenal axis (HPA) functioning and shorter telomere length in offspring. In contrast, research suggests that individual differences in mindfulness may act as a protective factor against one's own telomere degradation. Currently, research has yet to investigate the association between longitudinal changes in maternal mental health (depressive symptoms and mindfulness) and salivary infant telomere length, and whether such changes might be mediated by alterations in infant cortisol response. In 48 mother-infant dyads, we investigated whether the changes in maternal mental health, when infants were 6–12 months of age, predicted change in infant cortisol reactivity and recovery over this period. We also investigated whether these changes in infant HPA functioning predicted subsequent infant salivary telomere length at 18 months of age. Furthermore, we investigated whether change in infant HPA functioning provided a potential pathway between changes in maternal mental health factors and infant salivary telomere length. Analyses revealed that increases in maternal depressive symptoms over that six-month period indirectly related to subsequent shorter infant telomere length through increased infant cortisol reactivity. Implications for the ways in which maternal mental health can impact offspring stress mechanisms related to aging and disease trajectories are discussed.
AB - Maternal depression has been suggested to be an independent risk factor for both dysregulated hypothalamic-pituitary-adrenal axis (HPA) functioning and shorter telomere length in offspring. In contrast, research suggests that individual differences in mindfulness may act as a protective factor against one's own telomere degradation. Currently, research has yet to investigate the association between longitudinal changes in maternal mental health (depressive symptoms and mindfulness) and salivary infant telomere length, and whether such changes might be mediated by alterations in infant cortisol response. In 48 mother-infant dyads, we investigated whether the changes in maternal mental health, when infants were 6–12 months of age, predicted change in infant cortisol reactivity and recovery over this period. We also investigated whether these changes in infant HPA functioning predicted subsequent infant salivary telomere length at 18 months of age. Furthermore, we investigated whether change in infant HPA functioning provided a potential pathway between changes in maternal mental health factors and infant salivary telomere length. Analyses revealed that increases in maternal depressive symptoms over that six-month period indirectly related to subsequent shorter infant telomere length through increased infant cortisol reactivity. Implications for the ways in which maternal mental health can impact offspring stress mechanisms related to aging and disease trajectories are discussed.
UR - http://www.scopus.com/inward/record.url?scp=85034651328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034651328&partnerID=8YFLogxK
U2 - 10.1016/j.psyneuen.2017.11.008
DO - 10.1016/j.psyneuen.2017.11.008
M3 - Article
C2 - 29161636
AN - SCOPUS:85034651328
SN - 0306-4530
VL - 88
SP - 38
EP - 46
JO - Psychoneuroendocrinology
JF - Psychoneuroendocrinology
ER -